• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 12
      The microbiota in radiotherapy-induced cancer immunosurveillance - 1 day(s) ago

      Nature Reviews Clinical Oncology – Radiotherapy has an established role in the treatment of many patients with cancer, with evidence suggesting that this modality can also have immunostimulatory…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! The microbiota in radiotherapy-induced cancer immunosurveillance https://t.co/ckTiLi3gbo

    • Mashup Score: 12
      The microbiota in radiotherapy-induced cancer immunosurveillance - 1 day(s) ago

      Nature Reviews Clinical Oncology – Radiotherapy has an established role in the treatment of many patients with cancer, with evidence suggesting that this modality can also have immunostimulatory…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! The microbiota in radiotherapy-induced cancer immunosurveillance https://t.co/ckTiLi3gbo

    • Mashup Score: 29
      Therapeutic targeting of mismatch repair-deficient cancers - 5 day(s) ago

      Nature Reviews Clinical Oncology – This comprehensive Review describes the biological function of the mismatch repair (MMR) machinery, the genomic sequelae of defects in this machinery and the…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Therapeutic targeting of mismatch repair-deficient cancers https://t.co/UaL4j9eIsb

    • Mashup Score: 29
      Therapeutic targeting of mismatch repair-deficient cancers - 6 day(s) ago

      Nature Reviews Clinical Oncology – This comprehensive Review describes the biological function of the mismatch repair (MMR) machinery, the genomic sequelae of defects in this machinery and the…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Therapeutic targeting of mismatch repair-deficient cancers https://t.co/UaL4j9eIsb

    • Mashup Score: 8
      EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma - 7 day(s) ago

      Nature Reviews Clinical Oncology – In these Evidence-Based Guidelines, a multidisciplinary panel of experts from the European Hematology Association and the European Myeloma Network provide key…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma https://t.co/mdDRScuion

    • Mashup Score: 7
      EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma - 8 day(s) ago

      Nature Reviews Clinical Oncology – In these Evidence-Based Guidelines, a multidisciplinary panel of experts from the European Hematology Association and the European Myeloma Network provide key…

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma https://t.co/mdDRScuion

    • Mashup Score: 5
      Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA - 27 day(s) ago

      Nature Reviews Clinical Oncology – Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Zanidatamab shows promise as first-line therapy for advanced-stage HER2+ GEA https://t.co/fl2gFcvTAB

    • Mashup Score: 5
      Second-line tarlatamab improves OS in SCLC - 28 day(s) ago

      Nature Reviews Clinical Oncology – Second-line tarlatamab improves OS in SCLC

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Second-line tarlatamab improves OS in SCLC https://t.co/9aMEzqk57O

    • Mashup Score: 1
      Robot-assisted laparoscopic surgery confers improved oncological outcomes - 28 day(s) ago

      Nature Reviews Clinical Oncology – Robot-assisted laparoscopic surgery confers improved oncological outcomes

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Robot-assisted laparoscopic surgery confers improved oncological outcomes https://t.co/TjPvOs6wIE

    • Mashup Score: 2
      Adding durvalumab to perioperative FLOT improves gastric cancer outcomes - 28 day(s) ago

      Nature Reviews Clinical Oncology – Adding durvalumab to perioperative FLOT improves gastric cancer outcomes

      Source: www.nature.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	NatRevClinOncol
        NatRevClinOncol

        New online! Adding durvalumab to perioperative FLOT improves gastric cancer outcomes https://t.co/Q0NXk3O7sq

    Load More

    NatureRevClinOncol

    @NatRevClinOncol

    The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings